5-Bromo-4-chloro-3-iodopyridin-2-amine, 98%, 250mg

6-(TRIFLUOROMETHYL)-1H-INDAZOL-5-AMINE, 95.0%, 250mg

Long working distance plan phase contrast Fluarex 40x/0.65 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

5-(3-Chlorophenyl)-2-(piperidin-1-yl)-[1,3]thiazolo[4,5-b]pyridine-7-carboxylic acid, 97%, 250mg

Azobenzene-3,3'-dicarboxylic acid, 97%, 5g

2-Methyl-6-nitro-1,2,3,4-tetrahydroisoquinoline, 97%, 1g

Ethyl 3-Amino-4,4,4-trifluorocrotonate>97.0%(GC)5g

2-Chloro-3,5-dibromo-4-methylpyridine, 95.0%, 10g

2-Chloromethyl-imidazo[1,2-a]pyridine;hydrochloride, 95.0%, 5g

(1R,2R)-(-)-N-(4-Toluenesulphonyl)-1,2-diphenylethylenediamine, 98.0%, 1g

4-Piperidin-1-ylmethyl-phenylamine, 95.0%, 5g

Pyrrolidin-2-yl-acetic acid tert-butyl ester, 95.0%, 1g

4-(2-Hydroxyethyl)thiomorpholine 1,1-Dioxide, 95.0%, 1g